A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group (Q45862712)
scientific article published in September 1999
Language:
(P31) (Q13442814)
(P304) 2325-2335
(P433) 14
(P478) 10
(P577) Wednesday, September 1, 1999
(P921) (Q213901)
(Q5452194)
(Q42824440)
(Q282142)
(P1433) (Q15757580)
(P1476) "A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group" (language: en)
(P2093) Shand N
Weber F
Mariani L
Bernstein M
Gianella-Borradori A
Long Z
Sorensen AG
Barbier N
other details
description scientific article published in September 1999

External Links